recomb / RECOMB

Robots.txt Information

Robot	Path	Permission
GoogleBot	/	✔
BingBot	/	✔
BaiduSpider	/	✔
YandexBot	/	✔
User-agent: * Disallow: /wp-admin/ Allow: /wp-admin/admin-ajax.php Sitemap:

Meta Tags

Title	RECOMB
Description	News Recomb Gene Therapy for RAG
Keywords	Recomb, gene, therapy, RAG, RAG!

Server Information

WebSite	recomb.eu
Host IP	185.87.248.238
Location	Netherlands

Related Websites

                        Site
                        Rank
                    

More to Explore

recomb.eu Valuation

US$1,407,599

Last updated: 2023-05-14 22:42:18

recomb.eu has Semrush global rank of 7,519,403. recomb.eu has an estimated worth of US$ 1,407,599, based on its estimated Ads revenue. recomb.eu receives approximately 162,416 unique visitors each day. Its web server is located in Netherlands, with IP address 185.87.248.238. According to SiteAdvisor, recomb.eu is safe to visit.

Traffic & Worth Estimates

Purchase/Sale Value	US$1,407,599
Daily Ads Revenue	US$1,300
Monthly Ads Revenue	US$38,980
Yearly Ads Revenue	US$467,756
Daily Unique Visitors	10,828
Note: All traffic and earnings values are estimates.

DNS Records

Host	Type	TTL	Data
recomb.eu.	A	14397	IP: 185.87.248.238
recomb.eu.	NS	86400	NS Record: ns00.skyberate.eu.
recomb.eu.	NS	86400	NS Record: ns01.skyberate.nl.
recomb.eu.	NS	86400	NS Record: ns00.skyberate.nl.
recomb.eu.	MX	14400	MX Record: 0 recomb.eu.

HtmlToTextCheckTime:2023-05-14 22:42:18

Home Project Partners Advisory board Investigators Institutes LUMC Inserm UCL Great Ormond Street Ospedale San Raffaele Hannover Medical School University of Ulm Wroclaw University Newcastle University IPOPI Batavia Biosciences Vall d’Hebron Hospital Bambino Gesù SCETIDE Sheba Medical Center LMU GeneWerk Partner area Impact Resources Leaflet Videos Contact News RECOMB Clinical trial for RAG1-SCID Develop Develop an autologous haematopoietic stem cell‒based gene therapy within a multinational, multicentre clinical trial for treating RAG1-SCID. Treat Treat the patients with the developed RAG1-SCID gene therapy eliminating complications and increasing survival. Impact Make gene therapy a realistic option for > 70% of all SCID patients in Europe with reduced healthcare costs. News Read more March 13, 2023 Ethical approval at Vallhebron Do you like it? 24 0 Read more March 1, 2023 Second patient recruited to our RAG1 trial Do you like it? 23 0 Read more About us The RECOMB consortium

HTTP Headers

HTTP/1.1 301 Moved Permanently
Date: Fri, 24 Dec 2021 03:41:27 GMT
Server: Apache
X-Pingback: http://www.recomb.eu/xmlrpc.php
X-Redirect-By: WordPress
Location: http://www.recomb.eu/
Vary: Accept-Encoding
Content-Type: text/html; charset=UTF-8

HTTP/1.1 200 OK
Date: Fri, 24 Dec 2021 03:41:29 GMT
Server: Apache
X-Pingback: http://www.recomb.eu/xmlrpc.php
Link: ; rel="https://api.w.org/", ; rel="alternate"; type="application/json", ; rel=shortlink
Vary: Accept-Encoding
Content-Type: text/html; charset=UTF-8

recomb.eu Whois Information

Domain: recomb.eu
Script: LATIN
NOT DISCLOSED!
Visit www.eurid.eu for webbased WHOIS.
Organisation: Skyberate Internet Services B.V.
Language: nl
Email: info@skyberate.nl
Name: Skyberate Internet Services B.V.
Website: https://www.skyberate.nl
ns01.skyberate.nl
ns00.skyberate.eu
ns00.skyberate.nl
Please visit www.eurid.eu for more info.

recomb.eu valuation and analysis